Thanh bên bài viết
Số lượt xem chi tiết bài báo: 22
Evaluation of some characteristics of platelet-rich plasma from umbilical cord blood
Nội dung chính của bài viết
Tóm tắt
The study aims to evaluate some characteristics of platelet-rich plasma (PRP) from umbilical cord blood.
Research on 6 umbilical cord blood samples compared with 6 donor venous blood samples, using the GeneWorld kit. The results show that PRP from umbilical cord blood had fewer red blood cells (0.105 (0.07 - 0.17) T/L, 0.32 (0.12 - 0.55), p < 0.01), higher platelet count (701.17 ± 124.75 G/L vs. 457.83 ± 88.95 G/L, p < 0.01) and higher platelet count concentration ratio (2.3 vs. 1.82; p < 0.05). The concentration of EGF in umbilical cord blood plasma was 85.478 ± 28.195 pg/ml, that of healthy donors was 74.973 ± 29.475 (p > 0.05) with VEGF concentrations of 88,090 (67,536 - 135.32) and 10,504 (4,094 - 16,029) pg/mL, respectively, p < 0.05. The EGF concentration in activated PRP from umbilical cord blood and adult blood was 115.72 (50.98 -178.96) pg/mL and 94.91 (50.92 - 159.28) pg/mL (p < 0.05), with VEGF being 281.48 (141.59 - 324.12) pg/mL and 32.6 (11.7 - 53.4) pg/ml, respectively, p < 0.01.
In conclusion, umbilical cord blood had normal hematological indices. PRP from umbilical cord blood had fewer red blood cells, higher platelet counts, platelet aggregation ratio, and VEGF concentration than PRP from adult blood. The VEGF concentration in activated PRP from umbilical cord blood was higher than that in adult blood.
Chi tiết bài viết
Từ khóa
Characteristics, platelet-rich plasma, umbilical blood
Tài liệu tham khảo
2. Page KM, Mendizabal A., Betz‐Stablein B., et al. (2014). Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality. Transfusion. 54(2): 340-352.
3. Dang Thi Thu Hang. (2021). Research on the application of the process of collecting, processing and preserving community umbilical cord blood stem cells. (Date of publication: December 2, 2020).
4. Schippinger G., Prüller F., Divjak M., et al. (2015). Autologous platelet-rich plasma preparations: influence of nonsteroidal anti-inflammatory drugs on platelet function. 3(6): 2325967115588896.
5. Murphy MB, Blashki D., Buchanan RM, et al. (2012). Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation. 33(21): 5308-5316.
6. Johnson KE and Wilgus TAJA (2014) Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. 3 (10): 647 - 661.
7. Fréchette J.-P., Martineau I., and Gagnon GJJ. (2005) Platelet-rich plasmas: growth factor content and roles in wound healing. 84 (5): 434 - 439.
8. Tian J., Li XJ, Ma Y.. et al. (2023). Correlation of bioactive components of platelet-rich plasma derived from human female adult peripheral blood and umbilical cord blood with age. 13 (1): 18428.
9. Rhéaume M.-E., Perreault J., Fournier D.. et al. (2022). Preparation and growth factor characterization of cord blood-derived plasma, serum, growth factor-rich plasma and induced serum. 149: 155756.
10. Nurmaulinda, D.S., Budi, A.S., Zarasade, L., & Utomo, B. (2021). Epidermal Growth Factor (EGF) represents the role of other growth factors contained in Platelet-Rich Plasma (PRP). bmj, 10, 2524.
11. Wilkinson HN and Hardman MJJO B. (2020). Wound healing: cellular mechanisms and pathological outcomes. 10 (9): 200223.